David Cordúa, right, leads The Lymbar. Photo by Dylan McEwan

A veteran Houston chef’s new Midtown bar and restaurant is taking shape. When it opens later this fall, The Lymbar will mark chef David Cordúa’s return to Houston's dining scene.

Cordúa's name is well known to Houston diners. The chef worked with his father, legendary Houston restaurateur Michael Cordúa, at Cordúa Restaurants — the hospitality group behind Churrascos, Americas, and Amazon Grill — before the duo parted ways with the company in 2018. They're teaming up again on this new project.

Located inside The Ion, Rice University’s innovation district in the former Sears in Midtown, The Lymbar describes itself as an all-day neighborhood craft cocktail bar and restaurant. Named for the street in Meyerland where Cordúa grew up, the restaurant will serve an eclectic menu of Latin and Mediterranean-inspired dishes in a space designed by local firm Gin Design Group (Eunice, Daily Gather).

“The Ion already has an exciting buzz of ‘greenergy’ with great minds, start-ups and entrepreneurs coming together. The Lymbar will be their living room,” Cordúa said in a statement. “The vibe is ‘Golden Girls Chic’ with inspiration from childhood nostalgia like ‘Where the Wild Things Are’ and Shel Silverstein.”

Cordúa provided CultureMap with a preview of some of the menu items he plans to serve at The Lymbar. Those looking for a bar snack may order the 'Rosespud', oversized potato and plantain chips served with dips such as onion dip, chimichurri, and red curry romesco or items such as foie gras doughnut holes, Monte Cristo empanadas with raspberry dill vinaigrette, and sweet corn flan with Cracker Jacks. The truffle twinkie that won him the top prize at the first Truffle Masters competition will also be available.

Meals will begin with seasonal small plates such as fresh corn gnocchi with smoked tomato sauce, labneh and basil as well as rotating flatbreads like caramelized onions with new potatoes. Entree options include a stuffed chicken ballotine with sherry cream sauce and morels that draws upon the chef’s French training or go South American with a dish like arroz tumbado with oven-roasted branzino.

Expect to see The Lymbar’s build-your-own-taco boards on Instagram. They’ll combine proteins such as chicken shawarma, achiote pork belly, and sesame-seasoned tri-tip with basmati rice and house sourdough pita.

The chef has recruited an experienced group to help him open the restaurant. They include: executive chef Adolfo Lopez, Jr. (Brenner’s on the Bayou, Churrascos); general manager Jaime Rangel (Cordúa Restaurants); manager Travis Wingate (Churrascos, La Griglia); and bar manager Sean Stapleton (The Refuge in the Woodlands).

“We’re the lobby bar of The Ion,” Cordúa added. “We’ll be a place that celebrates the creativity and innovative spirit that makes Houston one of the best cities in the world.”

Already home to a location of Common Bond On-The-Go and Second Draught, a craft beer bar, The Ion will also soon welcome Late August, a Afro-Asian restaurant from Houston chef and Top Chef finalist Dawn Burrell.

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Biosciences startup becomes Texas' first decacorn after latest funding

A Dallas-based biosciences startup whose backers include millionaire investors from Austin and Dallas has reached decacorn status — a valuation of at least $10 billion — after hauling in a series C funding round of $200 million, the company announced this month. Colossal Biosciences is reportedly the first Texas startup to rise to the decacorn level.

Colossal, which specializes in genetic engineering technology designed to bring back or protect various species, received the $200 million from TWG Global, an investment conglomerate led by billionaire investors Mark Walter and Thomas Tull. Walter is part owner of Major League Baseball’s Los Angeles Dodgers, and Tull is part owner of the NFL’s Pittsburgh Steelers.

Among the projects Colossal is tackling is the resurrection of three extinct animals — the dodo bird, Tasmanian tiger and woolly mammoth — through the use of DNA and genomics.

The latest round of funding values Colossal at $10.2 billion. Since launching in 2021, the startup has raised $435 million in venture capital.

In addition to Walter and Tull, Colossal’s investors include prominent video game developer Richard Garriott of Austin and private equity veteran Victor Vescov of Dallas. The two millionaires are known for their exploits as undersea explorers and tourist astronauts.

Aside from Colossal’s ties to Dallas and Austin, the startup has a Houston connection.

The company teamed up with Baylor College of Medicine researcher Paul Ling to develop a vaccine for elephant endotheliotropic herpesvirus (EEHV), the deadliest disease among young elephants. In partnership with the Houston Zoo, Ling’s lab at the Baylor College of Medicine has set up a research program that focuses on diagnosing and treating EEHV, and on coming up with a vaccine to protect elephants against the disease. Ling and the BCMe are members of the North American EEHV Advisory Group.

Colossal operates research labs Dallas, Boston and Melbourne, Australia.

“Colossal is the leading company working at the intersection of AI, computational biology, and genetic engineering for both de-extinction and species preservation,” Walter, CEO of TWG Globa, said in a news release. “Colossal has assembled a world-class team that has already driven, in a short period of time, significant technology innovations and impact in advancing conservation, which is a core value of TWG Global.”

Well-known genetics researcher George Church, co-founder of Colossal, calls the startup “a revolutionary genetics company making science fiction into science fact.”

“We are creating the technology to build de-extinction science and scale conservation biology,” he added, “particularly for endangered and at-risk species.”

Houston investment firm names tech exec as new partner

new hire

Houston tech executive Robert Kester has joined Houston-based Veriten, an energy-focused research, investment and strategy firm, as technology and innovation partner.

Kester most recently served as chief technology officer for emissions solutions at Honeywell Process Solutions, where he worked for five years. Honeywell International acquired Houston-based oil and gas technology company Rebellion Photonics, where Kester was co-founder and CEO, in 2019.

Honeywell Process Solutions shares offices in Houston with the global headquarters of Honeywell Performance Materials and Technologies. Honeywell, a Fortune 100 conglomerate, employs more than 850 people in Houston.

“We are thrilled to welcome Robert to the Veriten team,” founder and CEO Maynard Holt said in a statement, “and are confident that his technical expertise and skills will make a big contribution to Veriten’s partner and investor community. He will [oversee] every aspect of what we do, with the use case for AI in energy high on the 2025 priority list.”

Kester earned a doctoral degree in bioengineering from Rice University, a master’s degree in optical sciences from the University of Arizona and a bachelor’s degree in laser optical engineering technology from the Oregon Institute of Technology. He holds 25 patents and has more than 25 patents pending.

Veriten celebrated its third anniversary on January 10, the day that the hiring of Kester was announced. The startup launched with seven employees.

“With the addition of Dr. Kester, we are a 26-person team and are as enthusiastic as ever about improving the energy dialogue and researching the future paths for energy,” Holt added.

Kester spoke on the Houston Innovators Podcast in 2021. Listen here

.